2022 | Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib | Kudo, Masatoshi; Finn, Richard S; Edeline, Julien; Cattan, Stéphane; Ogasawara, Sadahisa; Palmer, Daniel H; Verslype, Chris; Zagonel, Vittorina; Fartoux, Laetitia; Vogel, Arndt; Sarker, Debashis; Verset, Gontran; Chan, Stephen L; Knox, Jennifer; Daniele, Bruno; Yau, Thomas; Gurary, Ellen B; Siegel, Abby B; Wang, Anran; ANN-LII CHENG ; Zhu, Andrew X | European journal of cancer (Oxford, England : 1990) | 38 | 35 | |